Dossier
obesity-related diseases
Coverage of obesity-related diseases in the Nexus archive.
- The promises and pitfalls of GLP-1 drugs
GLP-1 drugs, approved 20 years ago for diabetes, have helped over 30 million U.S. patients reduce weight but are associated with troubling side effects. Experts suggest potential use in treating obesity-related diseases like cancer, though patient reactions vary widely.
- UK researchers develop tool to identify people most at risk of obesity-related diseases
UK researchers have developed a data tool to identify individuals most at risk of obesity-related diseases, which could help the NHS prioritize access to limited weight-loss medications. The tool aims to address the growing concern of obesity in England, where two-thirds of adults are overweight or obese.